These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32719966)

  • 1. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.
    Gao P; Ye L; Cheng H; Li H
    Cell Mol Neurobiol; 2021 Oct; 41(7):1431-1440. PubMed ID: 32719966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
    Kaur I; Behl T; Sundararajan G; Panneerselvam P; Vijayakumar AR; Senthilkumar GP; Venkatachalam T; Jaglan D; Yadav S; Anwer K; Fuloria NK; Sehgal A; Gulati M; Chigurupati S
    Neurotox Res; 2023 Dec; 41(6):698-707. PubMed ID: 37847429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular clusterin interacts with brain isoforms of the bridging integrator 1 and with the microtubule-associated protein Tau in Alzheimer's disease.
    Zhou Y; Hayashi I; Wong J; Tugusheva K; Renger JJ; Zerbinatti C
    PLoS One; 2014; 9(7):e103187. PubMed ID: 25051234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.
    Holler CJ; Davis PR; Beckett TL; Platt TL; Webb RL; Head E; Murphy MP
    J Alzheimers Dis; 2014; 42(4):1221-7. PubMed ID: 25024306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging Integrator 1 (BIN1) Genotypes Mediate Alzheimer's Disease Risk by Altering Neuronal Degeneration.
    Wang HF; Wan Y; Hao XK; Cao L; Zhu XC; Jiang T; Tan MS; Tan L; Zhang DQ; Tan L; Yu JT;
    J Alzheimers Dis; 2016 Mar; 52(1):179-90. PubMed ID: 27003210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
    Glennon EB; Whitehouse IJ; Miners JS; Kehoe PG; Love S; Kellett KA; Hooper NM
    PLoS One; 2013; 8(10):e78806. PubMed ID: 24205320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
    Chapuis J; Hansmannel F; Gistelinck M; Mounier A; Van Cauwenberghe C; Kolen KV; Geller F; Sottejeau Y; Harold D; Dourlen P; Grenier-Boley B; Kamatani Y; Delepine B; Demiautte F; Zelenika D; Zommer N; Hamdane M; Bellenguez C; Dartigues JF; Hauw JJ; Letronne F; Ayral AM; Sleegers K; Schellens A; Broeck LV; Engelborghs S; De Deyn PP; Vandenberghe R; O'Donovan M; Owen M; Epelbaum J; Mercken M; Karran E; Bantscheff M; Drewes G; Joberty G; Campion D; Octave JN; Berr C; Lathrop M; Callaerts P; Mann D; Williams J; Buée L; Dewachter I; Van Broeckhoven C; Amouyel P; Moechars D; Dermaut B; Lambert JC;
    Mol Psychiatry; 2013 Nov; 18(11):1225-34. PubMed ID: 23399914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant accrual of BIN1 near Alzheimer's disease amyloid deposits in transgenic models.
    De Rossi P; Andrew RJ; Musial TF; Buggia-Prevot V; Xu G; Ponnusamy M; Ly H; Krause SV; Rice RC; de l'Estoile V; Valin T; Salem S; Despa F; Borchelt DR; Bindokas VP; Nicholson DA; Thinakaran G
    Brain Pathol; 2019 Jul; 29(4):485-501. PubMed ID: 30506549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
    De Rossi P; Buggia-Prévot V; Clayton BL; Vasquez JB; van Sanford C; Andrew RJ; Lesnick R; Botté A; Deyts C; Salem S; Rao E; Rice RC; Parent A; Kar S; Popko B; Pytel P; Estus S; Thinakaran G
    Mol Neurodegener; 2016 Aug; 11(1):59. PubMed ID: 27488240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease risk gene
    Voskobiynyk Y; Roth JR; Cochran JN; Rush T; Carullo NV; Mesina JS; Waqas M; Vollmer RM; Day JJ; McMahon LL; Roberson ED
    Elife; 2020 Jul; 9():. PubMed ID: 32657270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model.
    Ponnusamy M; Wang S; Yuksel M; Hansen MT; Blazier DM; McMillan JD; Zhang X; Dammer EB; Collier L; Thinakaran G
    Brain; 2023 Apr; 146(4):1561-1579. PubMed ID: 36059072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
    Franzmeier N; Rubinski A; Neitzel J; Ewers M;
    Nat Commun; 2019 Apr; 10(1):1766. PubMed ID: 30992433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease.
    Thomas S; Hoxha K; Tran A; Prendergast GC
    J Cell Biochem; 2019 Oct; 120(10):18320-18331. PubMed ID: 31211444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BIN1 favors the spreading of Tau via extracellular vesicles.
    Crotti A; Sait HR; McAvoy KM; Estrada K; Ergun A; Szak S; Marsh G; Jandreski L; Peterson M; Reynolds TL; Dalkilic-Liddle I; Cameron A; Cahir-McFarland E; Ransohoff RM
    Sci Rep; 2019 Jul; 9(1):9477. PubMed ID: 31263146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sTREM2 Mediates the Correlation Between BIN1 Gene Polymorphism and Tau Pathology in Alzheimer's Disease.
    Guo F; Tan MS; Hu H; Ou YN; Zhang MZ; Sheng ZH; Chi HC; Tan L;
    J Alzheimers Dis; 2024; 101(2):693-704. PubMed ID: 39240638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease BIN1 coding variants increase intracellular Aβ levels by interfering with BACE1 recycling.
    Perdigão C; Barata MA; Burrinha T; Guimas Almeida C
    J Biol Chem; 2021 Sep; 297(3):101056. PubMed ID: 34375641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alzheimer's disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons.
    Saha O; Melo de Farias AR; Pelletier A; Siedlecki-Wullich D; Landeira BS; Gadaut J; Carrier A; Vreulx AC; Guyot K; Shen Y; Bonnefond A; Amouyel P; Tcw J; Kilinc D; Queiroz CM; Delahaye F; Lambert JC; Costa MR
    Mol Psychiatry; 2024 Sep; 29(9):2634-2646. PubMed ID: 38514804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.